{"id":"https://openalex.org/W2000470201","doi":"https://doi.org/10.1002/cncr.21033","title":"High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib","display_name":"High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib","alternate_titles":[],"publication_year":2005,"publication_date":"2005-04-20","ids":{"openalex":"https://openalex.org/W2000470201","doi":"https://doi.org/10.1002/cncr.21033","mag":"2000470201","pmid":"https://pubmed.ncbi.nlm.nih.gov/15844174"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.21033","doi":"https://doi.org/10.1002/cncr.21033","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.21033","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000470201"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033270808","display_name":"Antonio M. P. Omuro","orcid":"https://orcid.org/0000-0003-4299-3664","observed_orcids":["https://orcid.org/0000-0003-4299-3664","https://orcid.org/0000-0002-7007-2224"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio M. P. Omuro","raw_affiliation_strings":["Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039791495","display_name":"Mark G. Kris","orcid":"https://orcid.org/0000-0002-7317-5341","observed_orcids":["https://orcid.org/0000-0002-7317-5341"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Kris","raw_affiliation_strings":["Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111578811","display_name":"Vincent A. Miller","orcid":"https://orcid.org/0000-0003-1667-3771","observed_orcids":["https://orcid.org/0000-0003-1667-3771"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent A. Miller","raw_affiliation_strings":["Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063327760","display_name":"Enrico Franceschi","orcid":"https://orcid.org/0000-0001-9332-4677","observed_orcids":["https://orcid.org/0000-0001-9332-4677"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrico Franceschi","raw_affiliation_strings":["Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102148600","display_name":"Neelam T. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelam Shah","raw_affiliation_strings":["Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046345302","display_name":"Daniel T. Milton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel T. Milton","raw_affiliation_strings":["Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Service Memorial Sloan Kettering Cancer Center New York New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084965180","display_name":"Lauren E. Abrey","orcid":"https://orcid.org/0009-0002-2035-2540","observed_orcids":["https://orcid.org/0009-0002-2035-2540"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren E. Abrey","raw_affiliation_strings":["Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":6.2613,"has_fulltext":false,"cited_by_count":235,"citation_normalized_percentile":{"value":0.9651727,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"103","issue":"11","first_page":"2344","last_page":"2348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8109999895095825},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cns-relapse","display_name":"central nervous system relapse","score":0.8679999709129333},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.8209999799728394},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7070000171661377},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9255015850067139},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9202795028686523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6110354661941528},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5465968251228333},{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.5296345353126526},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4959321916103363},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4828813374042511},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4755941331386566},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.46719810366630554},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46590882539749146},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4333891272544861},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.41931843757629395},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3998260796070099},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3749120235443115},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3575325012207031}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008577","descriptor_name":"Meningeal Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.21033","doi":"https://doi.org/10.1002/cncr.21033","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.21033","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:15844174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15844174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1981692336","https://openalex.org/W1982372171","https://openalex.org/W1990936385","https://openalex.org/W2013070755","https://openalex.org/W2017550329","https://openalex.org/W2042702856","https://openalex.org/W2043696829","https://openalex.org/W2051767374","https://openalex.org/W2111710483","https://openalex.org/W2120718661","https://openalex.org/W2129455899","https://openalex.org/W2139236349","https://openalex.org/W2145653040","https://openalex.org/W2146404049","https://openalex.org/W2160008014","https://openalex.org/W2161821474","https://openalex.org/W2167368130","https://openalex.org/W2200358793","https://openalex.org/W3190307202"],"related_works":["https://openalex.org/W140405015","https://openalex.org/W2528998649","https://openalex.org/W2115091425","https://openalex.org/W2143698821","https://openalex.org/W3490365","https://openalex.org/W1981801627","https://openalex.org/W2369607948","https://openalex.org/W2372943964","https://openalex.org/W2129455899","https://openalex.org/W2081830690"],"abstract_inverted_index":{"BACKGROUND:":[0],"Gefitinib":[1],"is":[2],"an":[3,13,257],"epidermal":[4],"growth":[5],"factor":[6],"receptor":[7],"tyrosine":[8],"kinase":[9],"inhibitor":[10],"that":[11],"induces":[12],"early":[14],"and":[15,32,64,78,82,125,155,172,179,228,234,288],"dramatic":[16],"response":[17,38,87,259],"in":[18,148,153,157,173,189,200,208,252,266],"10%":[19],"of":[20,34,70,74,107,127,145,166,183,215,249,263,279,285],"patients":[21,48,94,129,151,185,202,232,253],"with":[22,49,52,96,186,233,254],"advanced":[23],"nonsmall":[24],"cell":[25],"lung":[26,171,193],"carcinoma":[27],"(NSCLC).":[28],"Long-":[29],"term":[30],"outcome":[31,84],"patterns":[33,69],"disease":[35,71,146,167,187,194,206,250,264],"recurrence":[36,147,168,188,207,251],"after":[37,85,256],"have":[39],"not":[40],"been":[41],"described.":[42],"METHODS:":[43],"The":[44,104,136,211,220,243],"authors":[45],"evaluated":[46],"139":[47,93],"NSCLC":[50,255],"treated":[51,95],"gefitinib":[53],"at":[54],"Memorial":[55],"Sloan-Kettering":[56],"Cancer":[57],"Center":[58],"(New":[59],"York,":[60],"NY)":[61],"between":[62],"1998":[63],"2002.":[65],"They":[66],"focused":[67],"on":[68],"recurrence,":[72],"risk":[73],"brain":[75],"metastases":[76,217],"(BM)":[77],"leptomeningeal":[79],"metastasis":[80],"(LM),":[81],"long-term":[83],"initial":[86,143,164,205,258],"to":[88,260],"gefitinib.":[89],"RESULTS:":[90],"Of":[91],"the":[92,108,116,128,142,163,170,177,184,190,209,267,286],"gefitinib,":[97,261],"21":[98],"(15%)":[99],"achieved":[100],"a":[101,246],"partial":[102],"response.":[103],"median":[105,117,221],"age":[106],"responders":[109,133],"was":[110,121,141,169,176,218,245],"64":[111],"years":[112],"(range,":[113,123],"38-87":[114],"years),":[115],"Karnofsky":[118],"performance":[119],"score":[120],"80":[122],"60-90),":[124],"4":[126],"were":[130,225],"men.":[131],"All":[132],"had":[134,192,204],"adenocarcinoma.":[135],"central":[137],"nervous":[138],"system":[139],"(CNS)":[140],"site":[144,165,248],"7":[149],"(33%)":[150],"(BM":[152],"5":[154],"LM":[156],"2).":[158],"In":[159],"9":[160],"(43%)":[161],"patients,":[162],"1":[174],"it":[175],"liver":[178],"bone.":[180],"Four":[181],"(57%)":[182],"CNS":[191,216,236,244,283],"under":[195],"control.":[196],"BM":[197],"also":[198],"developed":[199],"2":[201],"who":[203],"lungs.":[210,268],"actuarial":[212],"5-year":[213],"incidence":[214],"60%.":[219],"overall":[222],"survival":[223,290],"periods":[224],"15":[226],"months":[227,230],"23":[229],"for":[231,274,294],"without":[235],"metastases,":[237],"respectively":[238],"(P":[239],"=":[240],"0.24).":[241],"CONCLUSIONS:":[242],"frequent":[247],"regardless":[262],"control":[265],"Patients":[269],"should":[270],"be":[271],"carefully":[272],"monitored":[273],"neurologic":[275],"symptoms.":[276],"Intrinsic":[277],"resistance":[278],"metastatic":[280],"clones,":[281],"incomplete":[282],"penetrance":[284],"drug,":[287],"longer":[289],"are":[291],"possible":[292],"explanations":[293],"this":[295],"high":[296],"incidence.":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000470201","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
